ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPGN OpGen Inc

0.4817
-0.0099 (-2.01%)
May 08 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 143,201
Bid Price 0.48
Ask Price 0.4812
News -
Day High 0.51

Low
0.165

52 Week Range

High
3.84

Day Low 0.4612
Company Name Stock Ticker Symbol Market Type
OpGen Inc OPGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0099 -2.01% 0.4817 19:59:49
Open Price Low Price High Price Close Price Prev Close
0.50 0.4612 0.51 0.4817 0.4916
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
399 143,201 $ 0.4800249 $ 68,740 - 0.165 - 3.84
Last Trade Time Type Quantity Stock Price Currency
18:40:59 1 $ 0.48 USD

OpGen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.81M 10.01M - 2.61M -37.28M -3.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

OpGen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OPGN Message Board. Create One! See More Posts on OPGN Message Board See More Message Board Posts

Historical OPGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.430.510.390.4540733293,4090.051712.02%
1 Month0.720.74670.390.5263875272,589-0.2383-33.10%
3 Months0.3710.990.3710.70287261,858,5220.110729.84%
6 Months0.570.990.240.6699164981,556-0.0883-15.49%
1 Year0.793.840.1650.66438061,688,802-0.3083-39.03%
3 Years46.2074.400.16514.011,489,242-45.72-98.96%
5 Years10.40256.000.16538.262,134,458-9.92-95.37%

OpGen Description

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Your Recent History

Delayed Upgrade Clock